Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment [Phase 3]
Phase 3 trial of subcutaneous tocilizumab in rheumatoid arthritis patients naïve to tocilizumab has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III) [Phase 2]
A Phase 2 trial evaluating atacicept in combination with rituximab in rheumatoid arthritis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents
A study investigated whether the formation of antibodies could predict clinical response in rheumatoid arthritis patients treated with four …
-
FDA approval · 2016-12-20FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.
-
EMA approval · 2016-12-16New oral treatment for rheumatoid arthritis
The EMA announces a new oral treatment for rheumatoid arthritis, indicating regulatory approval and availability for patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Antifolate Effectiveness in Arthritis [Phase 2]
A Phase 2 clinical trial update evaluating an antifolate therapy for rheumatoid arthritis and adjuvant arthritis.
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants [Phase 3]
Phase 3 trial evaluating tocilizumab as monotherapy or with methotrexate and/or other DMARDs in rheumatoid arthritis completed enrollment an…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing ABP 501 to adalimumab in moderate-to-severe rheumatoid arthritis demonstrated efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Long-Term Assessment of Safety and Physical Function With AMG 108 in RA [Phase 2]
A Phase 2 long-term study of AMG 108 in rheumatoid arthritis reports safety and physical function outcomes.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: A Study on Rheumatoid Arthritis Patients Treated With Rituximab
This document reports on a completed clinical trial evaluating rituximab in patients with rheumatoid arthritis. The sponsor listed is Hoffma…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)
This document reports a completed safety study evaluating abatacept for treating rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: High Intensity Interval Training and Rheumatoid Arthritis [NA]
A completed clinical trial from Duke University assessed high-intensity interval training in individuals with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously [Phase 1]
Phase 1 pharmacokinetics, safety and tolerability study of a single 125 mg subcutaneous dose of abatacept in rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)
A non-interventional observational study of rheumatoid arthritis patients treated with tocilizumab (RoActemra/Actemra) completed; results we…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)
Completed trial evaluating tocilizumab in active rheumatoid arthritis patients with an inadequate response to non-biologic DMARDs; results w…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis [Phase 2]
A Phase II clinical trial evaluating the safety and efficacy of GSK315234A in patients with rheumatoid arthritis has completed.
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate [Phase 2]
A Phase 2 dose-ranging trial of JNJ-39758979 in patients with active rheumatoid arthritis on methotrexate has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Curcuma Longa L in Rheumatoid Arthritis [Phase 1]
A Phase 1 trial evaluating Curcuma longa L. (turmeric) for rheumatoid arthritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA). [Phase 3]
Long-term extension study assessing safety and efficacy of subcutaneous tocilizumab in adults with rheumatoid arthritis. The Phase 3 trial i…
-
CLINICAL_TRIALS research · 2016-11-28Clinical Trial Update: Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients [NA]
This clinical trial update investigates predicting and analyzing the clinical relevance of anti-biopharmaceutical immunization to minimize i…
-
FDA approval · 2016-11-25FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's diclofenac sodium and misoprostol as an original ANDA, enabling a generic version of the diclo…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and initial clinical activity of AMP-110 in subjects with rheumatoid …
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Occupational Performance Problems in Individuals With Rheumatoid Arthritis
This clinical trial update notes that the study investigating occupational performance problems in people with rheumatoid arthritis has been…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Observational Study of Golimumab Intravenous Infusion
An observational study of intravenous golimumab for rheumatoid arthritis has been terminated. The sponsor is Janssen Inc., and the document …
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Effect of a Thin Customized Insole in RA [NA]
A completed clinical trial evaluating the effect of a thin customized insole on rheumatoid arthritis outcomes.